Bank of America
TTRX

Bank of America’s Turn Therapeutics TTRX Stock Holding History

Bank of America’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.2K Hold
14,124
– – ﹤0.01% 5613
2025
Q4 		$55.6K Buy
+14,124
New +$58.9K ﹤0.01% 5812

Other funds holding TTRX

DI
DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America's TTRX Position: Q1 2026 in Review

Bank of America held its Turn Therapeutics (TTRX) position steady in Q1 2026 at 14,124 shares worth $45.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5613.

Bank of America first reported a position in TTRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $55.6K in Q4 2025. 20 funds tracked by Wall St. Rank hold TTRX as of Q1 2026.

  • Bank of America held 14,124 shares of Turn Therapeutics worth $45.2K as of Q1 2026.
  • Bank of America left its Turn Therapeutics share count unchanged in Q1 2026.
  • Turn Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5613 holding.
  • Bank of America first reported a position in Turn Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Bank of America's Turn Therapeutics position peaked at $55.6K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Turn Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.